| Company Name: |
Shanghai meikai technology co., ltd
|
| Tel: |
021-18721550-091 18721550091 |
| Email: |
yangdong@pharma.com |
| Products Intro: |
Product Name:7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one
CAS:2056122-65-5
Purity:>95% Package:10 mg|25 mg| Remarks:MC012559
|
|
| | 7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one Basic information |
| | 7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one Chemical Properties |
| density | 1.418±0.06 g/cm3(Predicted) | | pka | 10.67±0.10(Predicted) |
| | 7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one Usage And Synthesis |
| Uses | 7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one is a HPK1 kinase inhibitor and has been shown to have in vivo antitumor activity. HPK1 kinase has been identified as a novel drug target for antitumor immunotherapy, as this kinase is involved in the extracellular-signaling pathways that inhibit the T-cell immuno antitumor response. |
| | 7-Amino-6-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-thieno[3,2-b]pyridin-5(4H)-one Preparation Products And Raw materials |
|